Primary |
Iron Deficiency Anaemia |
36.8% |
Anaemia |
27.6% |
Iron Deficiency |
9.3% |
Product Used For Unknown Indication |
6.0% |
Renal Failure Chronic |
6.0% |
Anaemia Of Pregnancy |
1.9% |
Drug Use For Unknown Indication |
1.2% |
Haemorrhagic Anaemia |
1.2% |
Serum Ferritin Decreased |
1.2% |
Anaemia Postoperative |
1.0% |
Haemoglobin Decreased |
1.0% |
Postpartum Haemorrhage |
1.0% |
Blood Iron Decreased |
0.9% |
Iron Deficiency Anemia |
0.9% |
Malabsorption |
0.9% |
Analgesic Therapy |
0.7% |
Premedication |
0.7% |
Anemia |
0.5% |
Hypertension |
0.5% |
Menorrhagia |
0.5% |
|
Vomiting |
14.1% |
Anaphylactoid Reaction |
7.1% |
Thrombophlebitis Superficial |
6.3% |
Urticaria |
6.3% |
Syncope |
5.9% |
Nausea |
4.8% |
Paraesthesia |
4.8% |
Phlebitis |
4.8% |
Rash |
4.8% |
Hypotension |
4.5% |
Pyrexia |
4.5% |
Skin Discolouration |
4.1% |
Thrombophlebitis |
4.1% |
Dyspnoea |
3.7% |
Infusion Site Extravasation |
3.7% |
Oedema Peripheral |
3.7% |
Hypersensitivity |
3.3% |
Wrong Technique In Drug Usage Process |
3.3% |
Pain |
3.0% |
Tachycardia |
3.0% |
|
Secondary |
Drug Use For Unknown Indication |
32.0% |
Product Used For Unknown Indication |
21.8% |
Anaemia |
10.8% |
Iron Deficiency Anaemia |
7.1% |
Pneumonia Legionella |
3.9% |
Crohn's Disease |
3.3% |
Hypertension |
2.5% |
Iron Deficiency |
2.3% |
Premedication |
2.3% |
Postoperative Analgesia |
1.9% |
Glycogen Storage Disease Type Ii |
1.7% |
Prophylaxis |
1.7% |
Anaesthesia |
1.2% |
Analgesic Therapy |
1.2% |
Infection |
1.2% |
Renal Transplant |
1.2% |
Staphylococcal Infection |
1.2% |
Lung Infection |
1.0% |
Epilepsy |
0.8% |
General Anaesthesia |
0.8% |
|
Stillbirth |
20.9% |
Vomiting |
8.8% |
Cytolytic Hepatitis |
7.7% |
Foetal Death |
7.7% |
Intra-uterine Death |
4.4% |
Jaundice |
4.4% |
Lymphopenia |
4.4% |
Renal Failure |
4.4% |
Thrombophlebitis Superficial |
4.4% |
Drug Exposure During Pregnancy |
3.3% |
Hypotension |
3.3% |
Iron Deficiency |
3.3% |
Phlebitis |
3.3% |
Pyrexia |
3.3% |
Syncope |
3.3% |
Upper Limb Fracture |
3.3% |
Weight Decreased |
3.3% |
Diarrhoea |
2.2% |
Intravascular Haemolysis |
2.2% |
Rash Maculo-papular |
2.2% |
|
Concomitant |
Drug Use For Unknown Indication |
33.7% |
Product Used For Unknown Indication |
29.8% |
Anaemia |
4.7% |
Nuclear Magnetic Resonance Imaging |
3.8% |
Renal Failure Chronic |
3.5% |
Crohn's Disease |
2.9% |
Hypertension |
2.8% |
Hyperparathyroidism Secondary |
2.7% |
Dialysis |
2.3% |
Pain |
1.8% |
Hyperphosphataemia |
1.7% |
Nuclear Magnetic Resonance Imaging Brain |
1.5% |
Nephrogenic Anaemia |
1.5% |
Prophylaxis |
1.4% |
Angiogram |
1.3% |
Peritoneal Dialysis |
1.2% |
Anticoagulant Therapy |
0.9% |
Haemodialysis |
0.9% |
Iron Deficiency Anaemia |
0.9% |
Vitamin Supplementation |
0.9% |
|
Vomiting |
16.8% |
Therapeutic Response Decreased |
12.0% |
Death |
6.1% |
Skin Tightness |
5.9% |
Haemoglobin Decreased |
5.0% |
Sepsis |
4.8% |
Nausea |
4.5% |
Nephrogenic Systemic Fibrosis |
4.1% |
Drug Ineffective |
3.9% |
Thirst |
3.9% |
Pyrexia |
3.6% |
Thrombocytopenia |
3.6% |
Urticaria |
3.6% |
Unresponsive To Stimuli |
3.4% |
Weight Decreased |
3.4% |
Aplasia Pure Red Cell |
3.2% |
Peritonitis Bacterial |
3.2% |
Pruritus |
3.2% |
Anaemia |
2.9% |
Pneumonia |
2.9% |
|